Trials / Completed
CompletedNCT04279964
Engaging Practices and Communities in the Development of Interventions to Promote HPV Vaccine Uptake
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,400 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 9 Years – 26 Years
- Healthy volunteers
- Not accepted
Summary
The overarching goal of this project is to implement Boot Camp Translation (BCT) methodology to translate the guidelines and evidence for human papillomavirus (HPV) vaccine into a practice and provider level intervention designed to improve its acceptability and uptake.
Detailed description
As a community engagement approach, Boot Camp Translation (BCT), is a 6-9-month iterative process that brings together multiple stakeholders, including patients, parents, and community members, to translate evidence-based guidelines and recommendations into locally relevant and meaningful messages, materials, and programs. Aim 1: Implement BCT in three geographically distinct Colorado communities to translate the current evidence for HPV vaccination into locally relevant interventions designed to increase vaccine uptake. Aim 2: Evaluate the impact of the BCT- designed intervention on practice-level HPV vaccination initiation rates. The long-term goal is to develop a replicable approach and low-cost method of increasing HPV vaccine uptake that is easily adaptable to different settings and sociodemographic contexts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Boot Camp Translation | Practices in the intervention arm will participate in the Boot Camp Translation process, where BCT Community Advisory group members will come together to develop and implement practice relevant materials to promote adolescent vaccination. |
| OTHER | Control | No intervention. Practices will continue to behave as usual. |
Timeline
- Start date
- 2020-05-08
- Primary completion
- 2024-08-31
- Completion
- 2024-08-31
- First posted
- 2020-02-21
- Last updated
- 2025-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04279964. Inclusion in this directory is not an endorsement.